Aurobindo Pharma consolidated net profit declines 21.73% in the September 2018 quarter

Sales rise 7.19% to Rs 4667.12 crore

Net profit of Aurobindo Pharma declined 21.73% to Rs 611.43 crore in the quarter ended September 2018 as against Rs 781.15 crore during the previous quarter ended September 2017. Sales rose 7.19% to Rs 4667.12 crore in the quarter ended September 2018 as against Rs 4354.18 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales4667.124354.18 7 OPM %21.1325.65 -PBDT977.381111.01 -12 PBT813.70978.93 -17 NP611.43781.15 -22

Powered by Capital Market - Live News